Workflow
其他综合
icon
Search documents
咸亨国际: 咸亨国际:国泰海通证券股份有限公司关于咸亨国际科技股份有限公司使用闲置募集资金暂时补充流动资金的核查意见
Zheng Quan Zhi Xing· 2025-08-25 17:04
国泰海通证券股份有限公司 关于咸亨国际科技股份有限公司 使用部分暂时闲置募集资金补充流动资金的核查意见 国泰海通证券股份有限公司(以下简称"国泰海通"或"保荐人")作为咸 亨国际科技股份有限公司(以下简称"咸亨国际"、"公司"或"发行人")首次 公开发行股票并在主板上市的持续督导保荐机构,根据《证券发行上市保荐业务 管理办法》《上市公司募集资金监管规则》《上海证券交易所股票上市规则》《上 海证券交易所上市公司自律监管指引第1号——规范运作》等有关规定,对公司 使用部分暂时闲置募集资金补充流动资金的事项进行了核查,具体情况如下: 一、募集资金基本情况 合计 133,585.50 47,470.93 经中国证券监督管理委员会《关于核准咸亨国际科技股份有限公司首次公开 发行股票的批复》(证监许可〔2021〕1776 号)核准,并经上海证券交易所同 意,公司向社会首次公开发行人民币普通股(A 股)4,001 万股,每股面值为 1 元,每股发行价格为 13.65 元,募集资金总额为 54,613.65 万元,扣除各项发行 费用(不含增值税)人民币 7,153.64 万元后,实际募集资金净额为人民币 47,460.01 ...
每经热评︱利欧股份拟携不超30亿元资金入市 上市公司投资需坚守三个原则
Mei Ri Jing Ji Xin Wen· 2025-08-11 07:13
Core Viewpoint - The announcement by Liao Co., Ltd. to invest up to 3 billion RMB in securities reflects the increasing attractiveness of the market and the recovering confidence of institutional and individual investors [1] Group 1: Investment Principles - The principle of "main business first" must be adhered to, ensuring that resources prioritize the needs of the main business to support long-term development [1] - Building a professional investment team is crucial for successful investment, as the complexity of the securities market requires high levels of expertise [2] - Public companies must strictly adhere to legal boundaries in their investment decisions to avoid regulatory penalties and protect shareholder interests [2] Group 2: Risk Management and Investment Strategy - Balancing risk and return requires a multi-dimensional approach, including a scientific risk-return assessment system and setting reasonable investment ratios based on risk tolerance [2] - Public companies should exemplify long-term and value investment principles, focusing on high-quality targets with long-term growth potential to mitigate short-term speculative risks [3] - Companies must avoid herd mentality and short-sighted trading behaviors to prevent unnecessary market volatility [3] Group 3: Market Impact - The participation of listed companies in securities investment not only demonstrates the enhanced market appeal but also injects vitality into the market [3] - Prudent decision-making, professional management, and compliance with regulations are essential for maximizing the interests of the company and its shareholders while contributing to the stable development of the capital market [3]
利欧股份(002131.SZ):拟使用不超过30亿元自有资金进行证券投资
Ge Long Hui A P P· 2025-08-08 11:23
格隆汇8月8日丨利欧股份(002131.SZ)公布,第七届董事会第十二次会议,会议审议通过了《关于使用 自有资金进行证券投资的议案》,同意公司及下属子公司使用最高额度不超过30亿元人民币(或投资时 点等值外币)的自有资金进行证券投资。该议案无需提交股东大会审议,授权期限自本次董事会审议通 过之日起12个月内有效。 ...
多措并举改善基本面 多家*ST公司“摘星脱帽”
Group 1 - Several *ST companies in the A-share market have successfully removed their delisting risk warnings since May, indicating a positive trend in the market [1][2] - Beijing Oriental Garden Environment Co., Ltd. (Oriental Garden) and Sichuan Jinshi Technology Co., Ltd. (Jinshi Technology) have both lifted their delisting risk warnings and changed their stock names [1] - Fujian Aonong Biotechnology Group Co., Ltd. (Aonong Biotechnology) and Shanxi Kexin Development Co., Ltd. (Kexin Development) have also successfully removed their delisting risk warnings, reflecting improved financial health [1] Group 2 - The recent trend of *ST companies removing delisting warnings is seen as a positive signal from a strategic perspective, as it indicates companies are focusing on core operations and restructuring [2] - Kexin Development reported a revenue of 375 million yuan and a net profit of approximately 39.98 million yuan for 2024, highlighting its successful business strategy [2] - Jinshi Technology achieved revenues of 258 million yuan from its energy storage business and 120 million yuan from its safety and fire protection business in 2024, demonstrating effective business transformation [2] Group 3 - Wento Holdings' successful removal of its delisting warning is attributed to its judicial restructuring, which improved its asset-liability structure and operational capabilities [3] - Aonong Biotechnology reported an annual revenue of 8.763 billion yuan and a net profit of 579 million yuan for 2024, following its bankruptcy restructuring [3] - The focus on core business and internal control quality is crucial for companies to improve their fundamentals and regain market confidence [3]